C. Ballantyne

Lipoprotein(a) Blood Levels and Cardiovascular Risk Reduction With Icosapent Ethyl.

J. Tardif, S. Ketchum, Michael Miller, 2024, Journal of the American College of Cardiology.

Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial

J. Tardif, P. Steg, S. Ketchum, 2024, European heart journal.

Lipoprotein(a) and Long-Term Cardiovascular Risk in a Multi-Ethnic Pooled Prospective Cohort.

W. Fan, Auris Browne, M. Budoff, 2024, Journal of the American College of Cardiology.

Statin utilization and cardiovascular outcomes in a real-world primary prevention cohort of older adults

S. Virani, Amber Makani, Oscar C. Marroquin, 2024, American journal of preventive cardiology.